Sera Prognostics Inc
Save
288.03M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression.
Similar securities
Based on sector and market capitalization
Report issue